Results 101 to 110 of about 98,224 (178)

APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial. [PDF]

JCO Precis Oncol
Shi X, Shetty AC, Wang J, Song Y, Sutera PA, Deek MP, Patel KR, Madan RA, Tang C, Proudfoot J, Davicioni E, Hussain A, Nguyen P, Sweeney C, Boytim E, Lacuna KP, Ryan CJ, Antonarakis ES, Tran PT, Hwang J.   +19 more
europepmc   +1 more source

Successful Management and Treatment Rechallenge Following Docetaxel-Induced Serpentine Supravenous Hyperpigmentation With Bullous Features: A Case Report. [PDF]

Clin Case Rep
Nair GR, Koutsis J, Poels D, Agar N, Warrier S, Kumar S.   +5 more
europepmc   +1 more source

A randomized, placebo-controlled, phase II study of docetaxel and platinum with or without erlotinib in recurrent/metastatic head and neck squamous-cell carcinomas. [PDF]

ESMO Open
William WN, Feng L, Kies MS, Ahmed S, Blumenschein GR, Glisson BS, Massarelli E, Johnson FM, Lu C, Le X, Kowalski LP, Kim ES.   +11 more
europepmc   +1 more source

Correction: PIGL promotes the docetaxel resistance of prostate cancer and is regulated by E3 ubiquitin ligase HUWE1. [PDF]

Front Immunol
Gao P, Lin BH, Zhang Z, Yi ZY, Ke ZB, Zhu ZH, Kang Z, Wei Y.   +7 more
europepmc   +1 more source

A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer. [PDF]

Cancer Res Commun
Choudhury AD, Zhong C, Xie W, Kochupurakkal BS, Wu PI, Riaz IB, Liu R, Yang DD, Folefac E, Lee D, Parikh M, Einstein DJ, Kessler ER, Mayer T, McKay RR, Pace A, Mouw KW, Chen L, Adalsteinsson VA, Van Allen EM, Kunos CA, Gore SD, Das B, D'Andrea A, Taplin ME, Shapiro GI.   +25 more
europepmc   +1 more source

Erianin suppresses prostate cancer progression and attenuates STAT3 signaling. [PDF]

Front Oncol
Yue Z, Zhao Y, Wang J, Wang F, Wang M, Li Z, Li Y, Li M.   +7 more
europepmc   +1 more source

A Novel Aerogel Delivery System Reduces Drug Resistance for Non-Small Cell Lung Cancer Combination Therapy. [PDF]

Cancer Med
Diao D, Tong Y, Zhai J, Mai S, Liu X, Rao X, Cai K.   +6 more
europepmc   +1 more source

Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study. [PDF]

Cancer Res Commun
Felip E, Kuo P, Garrido P, Chouaid C, Mountzios G, Tiseo M, Daniel DB, Zavodovskaya M, Tang S, Su-Feher L, Patel R, Park JK, Jürgensmeier JM, Summers Y.   +13 more
europepmc   +1 more source

Experimental evaluation of <i>Curcuma Longa</i> in docetaxel-induced systemic toxicity: Functional hepatorenal and target organ analysis. [PDF]

Exp Ther Med
Huber IMT, Lourenço ELB, Bellettini ST, Donadel G, Matumoto JFV, Pelloso SM, Carvalho MDB, Rossoni SL, Colferai MMT, Colferai DR, Cuman RKN, Velasquez LG.   +11 more
europepmc   +1 more source